Key Takeaways Hologic shareholders approved Blackstone & TPG's take-private deal at up to $79/share.Hologic's Diagnostics revenues fell 2.7%, with molecular tests and Asia-Pacific sales under pressure.HOLX trades near its buyout price and at a premium versus peers, limiting upside potential.Hologic (HOLX) closed yesterday’s trading session at $75.05, down 0.1% from the previous close. The stock now sits nearly 1.2% below the buyout cash offer of $76 per share from Blackstone & TPG. Announced in October 2025 ...